Back to products
Orlistat
Orlistat Price range: $ 59,00 through $ 455,00

Orlijohn

Price range: $ 57,00 through $ 335,00

Orlijohn is an effective medication designed to support long-term weight management in individuals struggling with obesity. The active ingredient works by inhibiting the enzyme lipase, which prevents the body from absorbing a significant portion of dietary fats. By reducing caloric intake from fat at the digestive level, this treatment helps users achieve their weight loss goals more efficiently when paired with a reduced-calorie diet. It is specifically formulated for adults with a high body mass index who are committed to making positive lifestyle changes. Consistent use of Orlijohn contributes to improved metabolic health and helps maintain a stable, healthy weight over time.

Active substance: Orlistat
SKU: Orlijohn Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Orlijohn: Patient Information Guide

Orlijohn belongs to a group of gastrointestinal medications classified as lipase inhibitors. It is indicated for weight management in individuals who meet specific body mass index criteria when used alongside a reduced-calorie, low-fat dietary plan. This medication is dispensed in accordance with applicable federal and state regulations in the United States.

Proper management of weight reduction therapy involves understanding how the active compound interacts with digestive enzymes, dietary fats, and concomitant medications. Patient compliance with dietary fat restrictions is essential to achieving therapeutic targets while minimizing localized gastrointestinal adverse effects.

Basic Information Overview

Active Ingredient Orlistat
Therapeutic Class Gastrointestinal Lipase Inhibitor
Dosage Form Oral Capsule
Route of Administration Oral
Primary Purpose Weight management and weight loss maintenance
Prescription Status Dispensed under federal and state pharmacy regulations
Food Interaction Must be taken with fat-containing meals (up to 30% calories from fat)

Clinical and Pharmacological Overview

How the Drug Works

Orlijohn exerts its action locally within the lumen of the stomach and small intestine. It forms a covalent bond with the active serine site of gastric and pancreatic lipases. Inactivating these enzymes prevents the hydrolysis of dietary triglycerides into absorbable free fatty acids and monoglycerides. Unabsorbed triglycerides cannot be systemically absorbed and are subsequently excreted unchanged in the feces. At the standard therapeutic dosage, Orlijohn inhibits the absorption of approximately 30% of ingested dietary fat.

Main Uses

Orlijohn is indicated for weight loss and weight maintenance in patients with obesity, defined as a Body Mass Index (BMI) of 30 kg/m² or greater. It is also indicated for overweight patients with a BMI of 27 kg/m² or greater who possess concurrent risk factors such as controlled hypertension, type 2 diabetes mellitus, or dyslipidemia. Therapeutic efficacy depends on the patient remaining on a nutritionally balanced, reduced-calorie diet where fat provides no more than 30% of total daily caloric intake.

Dosing Schedule

The standard dosage for adults is one 120 mg capsule taken three times daily with each main meal containing fat. The medication may be taken during the meal or up to 1 hour after completing the meal. If a meal is missed or if a meal contains no dietary fat, the dose for that specific meal should be omitted. Doses above 120 mg three times daily have not been shown to produce additional clinical efficacy or superior weight loss outcomes.

How It’s Absorbed and Eliminated

Systemic absorption of the active compound is minimal. Following oral administration, plasma concentrations of intact orlistat remain generally undetectable (< 5 ng/mL). There is no evidence of significant systemic accumulation. Fecal excretion represents the primary route of elimination, accounting for approximately 97% of the administered dose, with 83% excreted as unchanged drug. Elimination of unabsorbed compound is typically complete within 48 to 72 hours post-administration.

What Not to Combine

Orlijohn decreases the gastrointestinal absorption of fat-soluble vitamins (A, D, E, and K) and beta-carotene. Patients should take a daily multivitamin supplement containing fat-soluble vitamins at bedtime, separated by at least 2 hours from any Orlijohn dose. Concomitant administration with cyclosporine requires strict timing separation; cyclosporine should be administered at least 3 hours before or 3 hours after Orlijohn to prevent reduced plasma levels of cyclosporine. Levothyroxine and Orlijohn should be separated by at least 4 hours, and thyroid function must be monitored. Patients taking warfarin or other oral anticoagulants require regular monitoring of International Normalized Ratio (INR) values due to potential alterations in vitamin K absorption.

Adverse Reactions

Adverse reactions associated with Orlijohn are primarily localized to the gastrointestinal tract and are directly related to the presence of unabsorbed fat in the bowel. Common reactions include oily spotting, abdominal flatulence with discharge, fecal urgency, fatty or oily stools, and increased frequency of defecation. These events generally occur early in treatment and tend to subside when dietary fat is maintained below 30% of total daily calories. Less common but serious adverse events reported in post-marketing surveillance include severe liver injury and acute oxalate nephrolithiasis, which may lead to renal failure in patients with pre-existing kidney dysfunction.

Important Precautions

Orlijohn is contraindicated in patients with chronic malabsorption syndrome or cholestasis, as well as those with known hypersensitivity to the drug or any formulation components. Caution is advised in individuals with a history of hyperoxaluria or calcium oxalate nephrolithiasis, as urinary oxalate excretion may increase during treatment. The safety and effectiveness of this agent have not been established in pediatric patients under 12 years of age. Patients should be monitored for signs of hepatic impairment, such as jaundice, dark urine, or upper right quadrant abdominal pain.

What to Avoid While Taking It

Dietary fat intake must be distributed evenly across three main meals per day. Patients should avoid consuming meals containing excessive fat, as high fat content markedly increases the frequency and severity of gastrointestinal adverse effects. While alcohol does not exhibit a direct pharmacokinetic interaction with lipase inhibition, high-calorie alcoholic beverages should be limited, as they add non-nutritional calories that counteract body weight management goals.

If You Skip a Dose

If a main meal is skipped or contains no fat, the corresponding dose of Orlijohn should be omitted. If a dose is missed during a fat-containing meal, it can be taken up to 1 hour after the meal. If more than 1 hour has elapsed since finishing the meal, the missed dose should be skipped entirely, and the normal dosing schedule should resume with the next scheduled meal. Patients should never double a dose to compensate for a missed capsule.

Signs of Improvement

Progress is typically evaluated by measuring reductions in body weight over time. Initial weight loss may be observed within the first 2 weeks of starting therapy alongside dietary adherence. Clinical response includes gradual weight reduction, decreased waist circumference, and potential secondary improvements in fasting blood glucose, total cholesterol, and blood pressure parameters. If a patient fails to lose at least 5% of initial body weight after 12 weeks of continuous therapy, treatment utility should be re-evaluated by a healthcare provider.

Storage and Expiration

Store Orlijohn at controlled room temperature between 20°C and 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F). Keep the container tightly closed to protect the capsules from moisture and direct light. Do not use this medication past the expiration date printed on the original packaging.

Common Questions

How does Orlijohn alter the absorption of dietary vitamins?

Because Orlijohn blocks the absorption of dietary fats, fat-soluble vitamins (A, D, E, and K) are also absorbed less efficiently. To prevent nutritional deficiencies, patients are advised to take a daily multivitamin supplement containing these fat-soluble vitamins. The supplement should be taken at bedtime, at least 2 hours apart from any Orlijohn administration.

Can Orlijohn be taken if a meal contains zero fat?

If a meal is skipped entirely or contains no dietary fat, the dose of Orlijohn for that meal should be omitted. The therapeutic action of the drug relies on binding to lipases to prevent fat hydrolysis; taking the medication in the absence of dietary fat provides no clinical benefit.

What steps are recommended if severe abdominal pain occurs?

Severe, persistent abdominal pain–especially if accompanied by nausea, vomiting, dark urine, or yellowing of the skin or eyes–requires immediate medical evaluation. While mild gastrointestinal discomfort is common with unabsorbed fat, severe pain may indicate rare secondary conditions such as cholelithiasis, pancreatitis, or liver injury.

Is it necessary to separate Orlijohn from thyroid medication?

Yes. Orlijohn can reduce the absorption of levothyroxine, leading to reduced thyroid hormone levels and potential hypothyroidism. Patients taking thyroid replacement therapy should separate their levothyroxine dose from Orlijohn by at least 4 hours and undergo regular thyroid function monitoring.

Does Orlijohn affect oral contraceptive efficacy?

Orlijohn does not directly alter the systemic pharmacokinetics of oral hormonal contraceptives. However, if severe diarrhea occurs as a secondary gastrointestinal side effect of Orlijohn, the absorption of oral contraceptives may be reduced. In such instances, patients should use an additional barrier method of contraception.

This text is for informational purposes only and does not constitute individual medical advice.

In accordance with FDA requirements.

Additional information
Dosage

120 mg

Package

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

Ενεργός Ουσία